MENU
XTLB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
XTL Biopharmaceuticals (XTLB) Ownership - Who owns XTL Biopharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
5 Badner Street
Phone
+972 36116600
Employees
4
Web
https://www.xtlbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.46M
P/E Ratio
N/A
Total Cash
133K
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.53
Dividend Yield
N/A
Total Cash/Share
0.02
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
XTLB
Capitalization
7.47M
P/E Ratio
N/A
Risk (Beta)
1.53
Dividend Yield
N/A
Total Cash
133K
Total Cash/Share
0.02
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
2.71M
P/B Ratio
3.01
Cash Flow
N/A
Earnings
-0.03
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
14.1M
Current Ratio
11.43
Current Revenue Per Employee
23916.67
Dividends Per Share - Security
N/A
EBITDA
630K
Float
N/A
Float - Current
N/A
Gross Income Margin
57.84
Revenue To Assets
-12.10
Shares Held By Institutions
233K
Shares Outstanding - Current
5.45M
Total Liabilities
223K
Total Volume MTD
N/A
Value
N/A
Gain YTD
54.935
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics to treat hepatitis and other infectious diseases, using human antibodies and synthetic chemicals
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
5 Badner Street
Phone
+972 36116600
Employees
4
Web
https://www.xtlbio.com